A Network Pharmacology to Explore the Mechanism of Astragalus Membranaceus in the Treatment of Diabetic Retinopathy

Table 1

Information of compounds from AM.

Number	Mol ID	Molecule name	Molecule weight	OB (%)	DL
1	MOL000211	Mairin	456.78	55.38	0.78
2	MOL000239	Jaranol	314.31	50.83	0.29
3	MOL000296	Hederagenin	414.79	36.91	0.75
4	MOL000033	(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R,5S)-5-propan-2-yloctan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta (a) phenanthren-3-ol	428.82	36.23	0.78
5	MOL000354	Isorhamnetin	316.28	49.6	0.31
6	MOL000371	3,9-di-O-Methylnissolin	314.36	53.74	0.48
7	MOL000374	5′-Hydroxyiso-muronulatol-2′,5′-di-O-glucoside	642.67	41.72	0.69
8	MOL000378	7-O-Methylisomucronulatol	316.38	74.69	0.3
9	MOL000379	9,10-Dimethoxypterocarpan-3-O-β-D-glucoside	462.49	36.74	0.92
10	MOL000380	(6aR,11aR)-9,10-Dimethoxy-6a,11a-dihydro-6H-benzofurano (3,2-c) chromen-3-ol	300.33	64.26	0.42
11	MOL000387	Bifendate	418.38	31.1	0.67
12	MOL000392	Formononetin	268.28	69.67	0.21
13	MOL000398	Isoflavanone	316.33	109.99	0.3
14	MOL000417	Calycosin	284.28	47.75	0.24
15	MOL000422	Kaempferol	286.25	41.88	0.24
16	MOL000433	FA	441.45	68.96	0.71
17	MOL000438	(3R)-3-(2-Hydroxy-3,4-dimethoxyphenyl)chroman-7-ol	302.35	67.67	0.26
18	MOL000439	Isomucronulatol-7,2′-di-O-glucosiole	626.67	49.28	0.62
19	MOL000442	1,7-Dihydroxy-3,9-dimethoxy pterocarpene	314.31	39.05	0.48
20	MOL000098	Quercetin	302.25	46.43	0.28
21	MOL000401	Astragaloside I	869.17	46.79	0.11
22	MOL000403	Astragaloside II	827.13	46.06	0.13
23	MOL000405	Astragaloside III	785.09	31.83	0.1
24	MOL000407	Astragaloside IV	785.09	22.5	0.15